Clinical Trials - BYSI

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT03294577Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced NeutropeniaUNKNOWNPHASE32019-10-232025-09-252020-09-25
NCT03102606Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3COMPLETEDPHASE32018-05-292021-02-082018-12-12
NCT04227990Plinabulin iv Solution in Prevention of TAC Induced NeutropeniaCOMPLETEDPHASE22017-11-272019-01-032018-10-15
NCT04345900Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2COMPLETEDPHASE22017-04-052018-04-202018-03-20
NCT02504489Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLCCOMPLETEDPHASE32015-122021-05-232021-03-23